Swiss Hemophilia Registry
NCT02512250 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 900
Last updated 2022-10-27
Summary
The Swiss Hemophilia Registry will collect data on the prophylactic and therapeutic use of factor concentrates in patients with hemophilia and other severe bleeding disorders in Switzerland.
Conditions
- Hemophilia and Other Severe Bleeding Disorders
Interventions
- OTHER
-
Registry
Sponsors & Collaborators
-
Swiss Hemophilia Network
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Clinical and Health-related Outcome of rFVIIIFc Prophylaxis
NCT04583930 ·Status: UNKNOWN
-
Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants
NCT03876301 ·Status: COMPLETED
-
Data Registry in Chinese Hemophilia A and B Patients
NCT07101224 ·Status: COMPLETED
-
Epidemiology and Immunology of Hemophilia A Inhibitors
NCT00005518 ·Status: COMPLETED
-
A Feasibility Study to Collect Data in Patients With Haemophilia
NCT00798499 ·Status: COMPLETED
-
Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
NCT02396862 ·Status: COMPLETED
-
Observational Registry of the Treatment of Glanzmann's Thrombasthenia
NCT01476423 ·Status: COMPLETED
-
Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa
NCT01856751 ·Status: UNKNOWN
-
Combining Registry Data in Haemophilia: TARGET H
NCT03264014 ·Status: COMPLETED
-
Register of Patients With haEmophilia A tReated With Afstyla®
NCT04675541 ·Status: COMPLETED
-
Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function
NCT02225483 ·Status: COMPLETED
-
Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells
NCT04805021 ·Status: RECRUITING
-
Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A
NCT00989196 ·Status: COMPLETED ·Phase: PHASE2
-
Turkish Acquired Haemophilia Registry
NCT01403740 ·Status: UNKNOWN
-
World Bleeding Disorders Registry Pilot Study
NCT02776826 ·Status: COMPLETED
-
National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
NCT00510042 ·Status: COMPLETED
-
Project to Update the Study of Congenital Haemophilia in Spain
NCT01959555 ·Status: COMPLETED
-
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
NCT02061033 ·Status: UNKNOWN
-
Multidisciplinary Evaluation of Patients With Hemophilia
NCT02198430 ·Status: COMPLETED
-
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
NCT02453542 ·Status: RECRUITING
-
A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A
NCT03061201 ·Status: COMPLETED ·Phase: PHASE2
-
A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI
NCT02207894 ·Status: RECRUITING
-
ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
NCT02078427 ·Status: COMPLETED
-
ATHN 7: Hemophilia Natural History Study
NCT03619863 ·Status: COMPLETED
-
UK - EHL Outcomes Registry
NCT02938156 ·Status: UNKNOWN